Revisión
Cronoterapia para reducción de riesgo cardiovascular
Chronotherapy for reduction of cardiovascular risk
a Laboratorio de Bioingeniería y Cronobiología, Atlantic Research Center for Information and Communication Technologies (atlanTTic), Universidad de Vigo, Vigo, España
b Department of Biomedical Engineering, Cockrell School of Engineering, The University of Texas at Austin, Austin, Texas, Estados Unidos
c Chief Parmacology Officer (CPO), Circadian Ambulatory Technology & Diagnostics (CAT&D), Santiago de Compostela, La Coruña, España
Leído
90
Vecesse ha leído el artículo
64
Total PDF
26
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2023 3 | 11 | 3 | 14 |
| 2021 11 | 1 | 0 | 1 |
| 2021 5 | 1 | 0 | 1 |
| 2021 3 | 0 | 2 | 2 |
| 2020 1 | 3 | 0 | 3 |
| 2020 12 | 3 | 2 | 5 |
| 2020 10 | 3 | 6 | 9 |
| 2020 8 | 1 | 4 | 5 |
| 2020 7 | 2 | 47 | 49 |
| 2020 6 | 1 | 0 | 1 |
